David Daly
Foundation Medicine has announced that David Daly intends to resign for personal reasons effective August 11. Daly currently serves as chief commercial officer and general manager of clinical oncology solutions for the company. No replacement has yet been named.
Philippe Goix
Avant Diagnostics has appointed Philippe Goix as president and CEO. Goix comes to Avant from Prism Health Diagnostics where he served as president, CEO, and co-founder. Before his time at Prism Health, he consulted for several healthcare companies, and has also served as president and CEO of Singulex, and president and CEO of Guava Technologies, now part of Merck Millipore.
Peter Meintjes
Omixon has appointed Peter Meintjes as CEO. Meintjes replaces current CEO Tim Hague who will step into a consultancy role and remains a shareholder of the company. Most recently, Meintjes served as chief commercial officer at Omixon. He joined the company in 2014.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.